Methodist Health System
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Methodist Health System sits in the top decile of US sponsors by registered trial count (#215 of 15,742 sponsors by registered trial count).
Methodist Health System: 125 sponsored US clinical trials, 36 recruiting.
Methodist Health System sponsors 125 registered US clinical trials on ClinicalTrials.gov, 36 of them currently recruiting, and 73 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is SBO - Small Bowel Obstruction, with 1 trials.
Top-decile sponsor footprint
Methodist Health System ranks in the top decile of sponsors by registered trial count (#215 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
73 of 78 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
125 total, page 1 of 3
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients
NCT07644091
Traumatic Cardiac Arrest
NCT07490171
Acute Subdural Hematoma
NCT07490197
Endoscopic Retrograde Cholangiopancreatography
NCT07490132
Cardiac Clearance vs G60 Hip Frailty Index
NCT07490184
Trauma Activation Criteria
NCT07490145
Validation of COMPAT-SF Spanish Translation
NCT06698302
Evidence-based Approach to Reduce Falls in Adult Patients
NCT06698315
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
NCT04090034
Enteric Anastomoses
NCT07490158
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
NCT07486362
Leadership Training Affect Physician Career Satisfaction
NCT06222411
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
NCT06223633
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
NCT06225193
A Retrospective Analysis of Outcomes in Patients with Hepatorenal Syndrome At Methodist Dallas Medical Center
NCT06095440
Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX
NCT06695416
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
NCT06223607
In Vivo Quantification of Cervical Collar Efficacy
NCT05262140
Head and Neck Trauma Registry, Protocol ID: 032.MBSI.2021.D
NCT05592899
Evaluation of Hepato-Pancreato-Biliary
NCT07565454
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
NCT06336850
Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis
NCT04714411
Perceived Coping, Meaning, and Joy at Work
NCT06336876
A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy
NCT05224791
Methodist Health System COVID-19 Patient Registry
NCT04477889
Volume Outcome Relationships and Effects
NCT06343597
Early-Onset Colorectal Cancer Patients Too Young for Screening
NCT07559825
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
NCT04182607
Evaluation of Outcomes from Treatment of Benign or Malignant Gastroesophageal Diseases
NCT04637256
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
NCT04055571
Peroral Endoscopic Myotomy for the Treatment of Achalasia
NCT04640753
Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.
NCT07494318
Pancreatic Cancer & Surgical Resection
NCT05170802
Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used)
NCT06336889
Antibiotic Use in Facial Fracture Post Injury
NCT04925531
Evaluation of Resection Techniques for Pancreatic Tumors
NCT05128890
Blunt Traumatic Aortic Injury
NCT07490015
Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections
NCT06096025
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
NCT05995262
Outcomes From Treatment Liver and Bile Duct Diseases
NCT04637243
Evaluation of the Analgesic Efficacy of Multimodal Pain Control Regimens That Aim to Limit the Use of Narcotics in Cholecystectomy and Hernia Repairs
NCT06095453
Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients with Delayed Graft Function
NCT06091995
The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates
NCT05935800
Thoracostomy Tube Irrigation: a Multi-Center Trial
NCT05935267
Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a Difference?
NCT05945550
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
NCT05170854
Methodist Acute Pancreatitis Protocol
NCT04214756
Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues
NCT06222424
Management of Extremity Injuries Registry
NCT07492758
Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol
NCT06223594
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
Where Methodist Health System enrollment is open (later-stage tilt)
36 recruiting of 125 indexed (29% open); 73 completed (58%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: SBO - Small Bowel Obstruction (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Methodist Health System: open-pipeline peers nationwide
Peers matched on 125 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Methodist Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 125 trials (± recruiting share)
- The Methodist Hospital Research Institute · 126 trials · 39% recruiting
- Stony Brook University · 127 trials · 19% recruiting
- Jazz Pharmaceuticals · 128 trials · 12% recruiting
- West Virginia University · 122 trials · 18% recruiting
Sponsors near 29% open enrollment (± trial volume)
- City of Hope Medical Center · 29% recruiting · 582 trials
- 89bio · 29% recruiting · 7 trials
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
Related
What to do with this Methodist Health System page
125 registered trials is a research-attention snapshot, not an endorsement of Methodist Health System or any single study.
- 36 of Methodist Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- SBO - Small Bowel Obstruction is the condition Methodist Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See SBO - Small Bowel Obstruction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Methodist Health System pipeline card: 125 registered trials from official public datasets.Report a data error.